Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Antiviral Drugs Market Size study, by Type (Branded, Generics), by Application (HIV, Hepatitis, Herpes, Influenza, Others), by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others) and Regional Forecasts 2020-2027

  • BIZ4192971
  • 200 Pages
  • February 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Antiviral Drugs Market is valued at approximately USD 37.26 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.2% over the forecast period 2020-2027. Antiviral drugs belong to the class of medication, which used for curing viral infections, such as HIV, hepatitis, influenza, and herpes. Usually, these drugs are overseen in the form of vaccines. In addition, most of these drugs are utilized for viral infections, even though a few broad-spectrum antiviral drugs are efficient alongside a comprehensive range of viruses. These drugs can reduce the ability of flu viruses to produce. When used as directed, antiviral drugs may often help to lessen the duration of flu symptoms in else healthy children and adults and may lower the severity of frequent flu symptoms. Therefore, these factors may promote the adoption of antiviral drugs for the treatment of viral infections all over the world. Therefore, the rise in prevalence of viral infections, such as HIV and influenza, along with the rise in R&D activities and development of advanced and newer formulations are the few factors responsible for the high CAGR of the market during the forecast period. As per the Avert organization, around 37.9 million people were affected by HIV (including 1.7 million children) in 2018, with a global prevalence of HIV of about 0.8% in the adult population. Similarly, according to the U.S. Department of Health & Human Services, in 2017, roughly 21.7 million individuals living with HIV, representing a surge of 8 million since 2010. Thus, the rise in prevalence of HIV diseases throughout the world will foster the demand for antiviral drugs in the forthcoming period. However, the high cost of drug development, coupled with availability of alternative treatment options, such as homeopathy and naturopathy, are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Antiviral Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in availability of sophisticated healthcare infrastructure, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of infectious diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Antiviral Drugs market across the Asia-Pacific region.

Major market player included in this report are:

Gilead Sciences

F. Hoffmann-La Roche AG

GlaxoSmithKline plc.

AbbVie

Merck & Co., Inc.

Johnson & Johnson Services, Inc.

Bristol-Myers Squibb Company

Cipla Inc.

Aurobindo Pharma

Dr. Reddy’s Laboratories Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Branded

Generics

By Application:

HIV

Hepatitis

Herpes

Influenza

Others

By Drug Class:

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Neuraminidase Inhibitors

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global Antiviral Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. Antiviral Drugs Market, by Region, 2018-2027 (USD Billion)

1.2.2. Antiviral Drugs Market, by Type, 2018-2027 (USD Billion)

1.2.3. Antiviral Drugs Market, by Application, 2018-2027 (USD Billion)

1.2.4. Antiviral Drugs Market, by Drug Class, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Antiviral Drugs Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Antiviral Drugs Market Dynamics

3.1. Antiviral Drugs Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Antiviral Drugs Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antiviral Drugs Market, by Type

5.1. Market Snapshot

5.2. Global Antiviral Drugs Market by Type, Performance - Potential Analysis

5.3. Global Antiviral Drugs Market Estimates & Forecasts by Type 2017-2027 (USD Billion)

5.4. Antiviral Drugs Market, Sub Segment Analysis

5.4.1. Branded

5.4.2. Generics

Chapter 6. Global Antiviral Drugs Market, by Application

6.1. Market Snapshot

6.2. Global Antiviral Drugs Market by Application, Performance - Potential Analysis

6.3. Global Antiviral Drugs Market Estimates & Forecasts by Application 2017-2027 (USD Billion)

6.4. Antiviral Drugs Market, Sub Segment Analysis

6.4.1. HIV

6.4.2. Hepatitis

6.4.3. Herpes

6.4.4. Influenza

6.4.5. Others

Chapter 7. Global Antiviral Drugs Market, by Drug Class

7.1. Market Snapshot

7.2. Global Antiviral Drugs Market by Drug Class - Potential Analysis

7.3. Global Antiviral Drugs Market Estimates & Forecasts by Drug Class 2017-2027 (USD Billion)

7.4. Antiviral Drugs Market, Sub Segment Analysis

7.4.1. DNA Polymerase Inhibitors

7.4.2. Reverse Transcriptase Inhibitors

7.4.3. Protease Inhibitors

7.4.4. Neuraminidase Inhibitors

7.4.5. Others

Chapter 8. Global Antiviral Drugs Market, Regional Analysis

8.1. Antiviral Drugs Market, Regional Market Snapshot

8.2. North America Antiviral Drugs Market

8.2.1. U.S. Antiviral Drugs Market

8.2.1.1. Type breakdown estimates & forecasts, 2017-2027

8.2.1.2. Application breakdown estimates & forecasts, 2017-2027

8.2.1.3. Drug Class breakdown estimates & forecasts, 2017-2027

8.2.2. Canada Antiviral Drugs Market

8.3. Europe Antiviral Drugs Market Snapshot

8.3.1. U.K. Antiviral Drugs Market

8.3.2. Germany Antiviral Drugs Market

8.3.3. France Antiviral Drugs Market

8.3.4. Spain Antiviral Drugs Market

8.3.5. Italy Antiviral Drugs Market

8.3.6. Rest of Europe Antiviral Drugs Market

8.4. Asia-Pacific Antiviral Drugs Market Snapshot

8.4.1. China Antiviral Drugs Market

8.4.2. India Antiviral Drugs Market

8.4.3. Japan Antiviral Drugs Market

8.4.4. Australia Antiviral Drugs Market

8.4.5. South Korea Antiviral Drugs Market

8.4.6. Rest of Asia Pacific Antiviral Drugs Market

8.5. Latin America Antiviral Drugs Market Snapshot

8.5.1. Brazil Antiviral Drugs Market

8.5.2. Mexico Antiviral Drugs Market

8.6. Rest of The World Antiviral Drugs Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Gilead Sciences

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. F. Hoffmann-La Roche AG

9.2.3. GlaxoSmithKline plc.

9.2.4. AbbVie

9.2.5. Merck & Co., Inc.

9.2.6. Johnson & Johnson Services, Inc.

9.2.7. Bristol-Myers Squibb Company

9.2.8. Cipla Inc.

9.2.9. Aurobindo Pharma

9.2.10. Dr. Reddy’s Laboratories Ltd.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global Antiviral Drugs market, report scope

TABLE 2. Global Antiviral Drugs market estimates & forecasts by region 2017-2027 (USD Billion)

TABLE 3. Global Antiviral Drugs market estimates & forecasts by Type 2017-2027 (USD Billion)

TABLE 4. Global Antiviral Drugs market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 5. Global Antiviral Drugs market estimates & forecasts by Drug Class 2017-2027 (USD Billion)

TABLE 6. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Global Antiviral Drugs market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. Global Antiviral Drugs market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. U.S. Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 23. U.S. Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 24. U.S. Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 25. Canada Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 26. Canada Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 27. Canada Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 28. UK Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 29. UK Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 30. UK Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 31. Germany Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 32. Germany Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 33. Germany Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 34. France Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 35. France Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 36. France Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 37. Spain Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 38. Spain Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 39. Spain Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 40. Italy Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 41. Italy Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 42. Italy Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 43. ROE Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 44. ROE Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 45. ROE Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 46. China Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 47. China Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 48. China Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 49. India Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 50. India Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 51. India Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 52. Japan Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 53. Japan Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 54. Japan Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 55. Australia Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 56. Australia Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 57. Australia Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 58. South Korea Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 59. South Korea Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 60. South Korea Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 61. ROPAC Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 62. ROPAC Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 63. ROPAC Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 64. Brazil Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 65. Brazil Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 66. Brazil Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 67. Mexico Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 68. Mexico Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 69. Mexico Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 70. ROLA Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 71. ROLA Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 72. ROLA Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 73. ROW Antiviral Drugs market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 74. ROW Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 75. ROW Antiviral Drugs market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 76. List of secondary sources, used in the study of global Antiviral Drugs market

TABLE 77. List of primary sources, used in the study of global Antiviral Drugs market

TABLE 78. Years considered for the study

TABLE 79. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research